The sell off is not isolated to MSB. Seems many stem cell types have been sold off in the last 2 weeks. In the below chart comparing a group of stem cell companies (XHJ in black, ATHX, CYTX, CMXI, PSTI, PRR, NBS, OSIR) you can see there has been a little sell off. Only OSIR has posted meaningful gains in the last two trading sessions.
Could Teva's formal confirmation of the PIII trial be a barometer for all stem cell companies? Are investors now waiting to see Teva throw their weight behind MSB? I dont know the answer but certainly there is (and has been in the past) some correlation here.
The sell off is not isolated to MSB. Seems many stem cell types...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |